A Small-sample, Real-world Study of Sintilimab Plus Bevacizumab/Cetuximab Plus XELOX Regimen for Conversion Therapy in Patients With Advanced Colorectal Cancer
Clinical trial NCT05544812 · UNKNOWN
Trial details
- NCT number
- NCT05544812
- Sponsor
- Xijing Hospital
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2022-05-01
- Primary completion
- 2022-09-15
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.